#weight loss drugs
4 stories
Novo CEO eyes M&A deals as weight-loss dominance slips
Novo Nordisk's turnaround plan failed to convince investors, prompting CEO Mike Doustdar to signal openness to acquisitions beyond obesity drugs.
CNBC · 2m
Novo's growth plan fails to impress investors
The Danish drugmaker's strategy to diversify beyond weight-loss drugs disappoints the market as patent expiry looms.
CNBC · 1m
What to know before starting GLP-1 weight loss drugs
These medications do more than help you lose weight, but they're not right for everyone.
Valleynewslive · 1m
A fake weight-loss peptide put someone in hospital
An Australian patient vomited so hard on a counterfeit peptide that their oesophagus tore, and the vial held something else entirely.
the Guardian · 1m